Analyst Price Targets — LAZ
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 30, 2026 2:17 pm | Michael Brown | UBS | $59.00 | $53.62 | TheFly | Lazard price target raised to $59 from $54 at UBS |
| January 7, 2026 11:45 am | Ryan Kenny | Morgan Stanley | $59.00 | $50.89 | TheFly | Lazard price target lowered to $59 from $61 at Morgan Stanley |
| December 11, 2025 5:38 am | Michael Brown | UBS | $54.00 | $50.46 | StreetInsider | UBS Assumes Lazard (LAZ) at Neutral |
| December 10, 2025 8:55 pm | — | Morgan Stanley | $61.00 | $50.46 | TheFly | Lazard price target lowered to $61 from $62 at Morgan Stanley |
| October 23, 2025 10:02 pm | James Yaro | Goldman Sachs | $46.00 | $49.12 | TheFly | Lazard price target raised to $46 from $45 at Goldman Sachs |
| July 14, 2025 9:44 am | Devin Ryan | JMP Securities | $60.00 | $53.21 | TheFly | Lazard price target raised to $60 from $55 at Citizens JMP |
| September 11, 2024 4:26 pm | Michael Brown | Wells Fargo | $51.00 | $45.57 | TheFly | Lazard initiated with an Equal Weight at Wells Fargo |
| July 26, 2024 1:40 pm | Stephen Biggar | Argus Research | $54.00 | $48.43 | StreetInsider | Lazard (LAZ) PT Raised to $54 at Argus |
| July 23, 2024 7:40 am | Ryan Kenny | Morgan Stanley | $56.00 | $43.73 | TheFly | Lazard price target raised to $56 from $53 at Morgan Stanley |
| April 9, 2024 2:29 am | Devin Ryan | JMP Securities | $52.00 | $41.23 | StreetInsider | Lazard (LAZ) PT Raised to $52 at JMP Securities, 'a “value play”' |
Latest News for LAZ
NEW YORK, Feb. 23, 2026 /PRNewswire/ -- Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.15340 per share on the Fund's outstanding common stock. The distribution is payable on March 23, 2026, to shareholders of record on March 10, 2026.
NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE: LAZ) today announced that John Koski and Rob Lowe joined the firm in New York as Managing Directors in the Healthcare Group, advising on transactions across the healthcare services sector. These appointments underscore Lazard's continued investment in its Healthcare Group and focus on providing thoughtful, high-quality strategic advice to executives,…
Eric Van Nostrand, Lazard Asset Management Chief Investment Officer, joins 'Money Movers' to discuss January's CPI data, tariffs, and more.
Lazard, Inc. (LAZ) Presents at UBS Financial Services Conference 2026 Transcript
Lazard, Inc. (LAZ) Presents at Bank of America Financial Services Conference 2026 Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LAZ.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.